Adial Pharmaceuticals, Inc. ADIL
Set alert
5.05 USD +1.34 +36.12%
At close · Oct 28
4.86 -0.19 -3.76%
After hours · Oct 28, 4:00 PM ET
3.82 Day range 5.15
1.31 52-week range 8.75
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 3.83
- Prev close
- 3.71
- Mkt cap
- 13.26M
- Vol
- 83.08K
- Avg vol
- 58.15K
- EPS
- -20.65
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.82
- High
- 5.15
- Forward P/E
- -0.79
- Beta
- 1.30
- Short ratio
- 0.65
- Inst. own
- 3.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 1.06
- 200-d avg
- 1.23
- 1y target
- 7.50
5D chart
Signals (21)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 28, 3:55 PM | 5 days ago |
| RSI: Overbought | Oct 28, 3:50 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:20 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:10 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 5 days ago |
| RSI: Overbought | Oct 28, 3:10 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:00 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:55 PM | 5 days ago |
| RSI: Overbought | Oct 28, 2:55 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 5 days ago |
| RSI: Overbought | Oct 28, 1:45 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:35 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 1:35 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 1:25 PM | 5 days ago |
| SMA: Bearish | Oct 28, 1:20 PM | 5 days ago |
| SMA: Bearish | Oct 28, 1:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 12:40 PM | 5 days ago |
| SMA: Bullish | Oct 28, 12:35 PM | 5 days ago |
Newest 20 of 21.
Analyst view
Consensus: none
Price target (mean) 7.50 +48.5% upside
Now 5.05
- Target (low)
- 7.00
- Target (mean)
- 7.50
- Target (high)
- 8.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.33 | -0.38 – -0.28 | -0.37 | +10.8% | 0 | 0.0% | 2 |
| Next quarter | -0.40 | -0.40 – -0.40 | -0.6812 | +41.3% | 0 | 0.0% | 1 |
| Current year | -2.78 | -2.84 – -2.71 | -4.91 | +43.5% | 0 | 0.0% | 2 |
| Next year | -1.42 | -1.51 – -1.32 | -2.78 | +49.0% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | Rodman & Renshaw | Initiated | — | Buy |